Dihydroetorphine hydrochloride sublingual tablets
Indication
This product is suitable for the analgesia of various severe pains, such as traumatic pain, postoperative pain, acute abdominal pain, dysmenorrhea, and advanced cancer pain, including severe pain that is not responsive to morphine or pethidine.
Precautions
1. Use with caution or reduce the dosage for patients with unconsciousness due to brain trauma or impaired lung function, liver or kidney function. It is contraindicated for patients with non-severe pain such as toothache, headache, rheumatism, hemorrhoid pain or pain from minor local tissue trauma. 2. Use with caution for the elderly. 3. Contraindicated for infants and immature newborns.
Special Population Medication
Precautions for children: Not for use in infants, young children, or immature newborns. Precautions for the elderly: Use with caution in the elderly.
Packaging Specification
40 μg
Manufacturer
Beijing Wellso Pharmaceutical Co., Ltd.
-
Founded in:
2000-06-28 -
Address:
No. 1, Jinguang North Street, Liangxiang Town Industrial Development Zone, Fangshan District, Beijing -
Tax NO.:
911100007226097157 -
Registered Funds:
105.6005 million yuan -
Website:
-
Email: